Editorial comment from Dr Shiota to Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy
Int J Urol
.
2014 Jun;21(6):583-4.
doi: 10.1111/iju.12397.
Epub 2014 Jan 9.
Author
Masaki Shiota
1
Affiliation
1
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. shiota@uro.med.kyushu-u.ac.jp.
PMID:
24404863
DOI:
10.1111/iju.12397
No abstract available
Publication types
Editorial
Comment
MeSH terms
Androgen Antagonists / therapeutic use*
Humans
Male
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology*
Substances
Androgen Antagonists